Trial Profile
The Effect of Detemir Compared to Exenatide and/or the Combination of Detemir and Exenatide on Glycemic Control and Weight in Patients With Type 2 Diabetes Mellitus Who Have Failed Oral Hypoglycemic Agents.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2011
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 24 Jun 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 24 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Mar 2010 New trial record